Preliminary research show conolidine might inhibit distinct ion channels, lowering neuronal excitability and restricting ache indicators. This mechanism is particularly appropriate in neuropathic suffering, wherever irregular signaling results in persistent pain. In addition, conolidine appears to affect G protein-coupled receptor (GPCR) pathways i